Cellcom Israel Announces Results of Annual General Meeting of Shareholders
CEL -SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites
More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference
Research and Markets: Myocarditis - Pipeline Review, H2 2014
Use this screen to find overlooked small- and mid-cap international stocks.